analyze the immune landscape of neuroblastoma pre- and post-chemotherapy and identify the NECTIN2-TIGIT axis as a crucial immune checkpoint, which correlates with dysfunction of T/NK cells. The gene discussed is TIGIT; the disease is neuroblastoma.